{
  "id": 19337863,
  "title": "Danger of sudden vision loss: the new FDA warning about GLP-1 weight loss injections",
  "url": "https://urgent.news/2026/11/10/danger-of-sudden-vision-loss-the-new-fda-warning-about-glp-1-weight",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-10T07:22:30.000Z",
  "source": {
    "name": "Ynetnews Culture",
    "slug": "ynetnews-culture",
    "url": "https://www.ynetnews.com/health_science/article/rj11eaegrgg"
  },
  "original_language": "en",
  "account": null,
  "summary": "FDA orders new warnings for GLP-1 weight-loss and diabetes drugs over a rare optic nerve condition that can cause permanent vision loss; regulators say the absolute risk is very low and advise patients not to stop treatment without medical guidance",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 4,
    "also_reported_by": [
      {
        "outlet": "Quartz",
        "title": "FDA is requiring weight loss drug makers to add a vision loss warning",
        "url": "https://urgent.news/2026/11/09/fda-is-requiring-weight-loss-drug-makers-to-add-a-vision-loss-warning",
        "published": "2026-11-09T18:50:30.000Z"
      },
      {
        "outlet": "CBS News",
        "title": "GLP-1s must now include warning for potential increased risk of vision loss, FDA announces",
        "url": "https://urgent.news/2026/11/10/glp-1s-must-now-include-warning-for-potential-increased-risk-of",
        "published": "2026-11-10T00:44:40.000Z"
      },
      {
        "outlet": "Global News",
        "title": "FDA to require vision loss warning on GLP-1 drug labels",
        "url": "https://urgent.news/2026/11/10/fda-to-require-vision-loss-warning-on-glp-1-drug-labels",
        "published": "2026-11-10T18:17:53.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}